3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
114
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Recurrence
17
Burkitt Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms, Plasma Cell
6
Lymphoma
6
Leukemia, Biphenotypic, Acute
5
Immunoglobulin Light-chain Amyloidosis
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lymphoma, B-Cell
4
Waldenstrom Macroglobulinemia
3
Neoplasm Metastasis
3
Nausea
3
Lung Neoplasms
3
Leukemia
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Paraproteinemias
2
Ovarian Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Down Syndrome
2
Interventions
Cyclophosphamide
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Busulfan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Melphalan
4
Azacitidine
4
venetoclax
3
fludarabine
3
Tacrolimus
3
Cyclosporine
3
Biopsy
3
Vorinostat
2
Specimen Handling
2
Rituximab
2
Methotrexate
2
Etoposide
2
Cytarabine
2
Antilymphocyte Serum
2
thymoglobulin
1
pegylated granulocyte colony-stimulating factor
1
merphos
1
ivosidenib
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
Thiotepa
1
TAK-243
1
Stem Cell Transplantation
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
Dexamethasone
×
90 days
×
Clear all
No trials found.